Cardiac Cannula Market Summary
The global cardiac cannula market was valued at USD 271.88 million in 2025 and is expected to reach USD 447.20 million by 2033, registering a compound annual growth rate (CAGR) of 6.45% from 2026 to 2033. This growth is primarily driven by the increasing prevalence of cardiovascular diseases across the globe, which continues to place a significant burden on healthcare systems. As the number of patients requiring surgical intervention rises, the volume of cardiac surgeries is also increasing steadily. This, in turn, is creating a strong demand for cardiac cannulas, which play a critical role in maintaining proper blood flow during various surgical procedures.
The market is also benefiting from the growing adoption of minimally invasive and robotic-assisted surgical techniques, which are gaining popularity due to their advantages such as reduced recovery time, lower risk of complications, and improved patient outcomes. Alongside this, the expansion of advanced cardiac care facilities and infrastructure is further supporting market growth. The increasing need for efficient and reliable extracorporeal circulation during complex cardiac procedures is another key factor driving demand for high-quality cannulas. Additionally, continuous advancements in cannula design, including improved flexibility, durability, and biocompatibility of materials, are enhancing product performance and safety. These technological improvements are encouraging healthcare providers to adopt more advanced solutions, thereby contributing to the overall expansion of the market.
Key Market Trends & Insights
- North America held the dominant position in the cardiac cannula market, accounting for the largest revenue share of 37.97% in 2025, supported by well-established healthcare infrastructure and high adoption of advanced medical technologies.
- Within North America, the United States accounted for the largest share of market revenue in 2025, driven by a high volume of cardiac procedures and strong presence of leading healthcare providers.
- Based on product type, the arterial cannulas segment led the market in 2025, owing to their essential role in facilitating blood flow from the heart to the extracorporeal circuit during surgery.
- In terms of application, the cardiopulmonary bypass (CPB) segment dominated the market with the largest revenue share in 2025, as CPB procedures are widely used in various types of cardiac surgeries.
- By material, the polyvinyl chloride (PVC) segment accounted for the largest market share in 2025, due to its cost-effectiveness, flexibility, and widespread use in medical-grade devices.
Order a free sample PDF of the Cardiac Cannula Market Intelligence Study, published by Grand View Research.
Market Size & Forecast
- 2025 Market Size: USD 271.88 Million
- 2033 Projected Market Size: USD 447.20 Million
- CAGR (2026-2033): 6.45%
- North America: Largest market in 2025
- Asia Pacific: Fastest growing market
Key Companies & Market Share Insights
The market is characterized by several established medical device manufacturers with strong global distribution networks and broad cardiovascular portfolios. Leading companies hold significant market share through continuous product innovation, regulatory approvals, and long-term partnerships with hospitals and cardiac centers, while smaller players compete by focusing on specialized designs and niche clinical applications.
Key Players
- Medtronic
- Edwards Lifesciences Corporation
- Braile Biomédica
- BD (Becton, Dickinson & Corporation)
- Surge Cardiovascular
- LivaNova PLC
- Getinge
- EUROSETS
- INVAMED
- Cardinal Health
- Andocor
- Xenios AG (Fresenius Medical Care)
- MERA (Senko Medical Instrument Mfg. Co., Ltd.)
- Prymax Healthcare LLP
- Vitalcor, Inc.
- Cormed Medizintechnik GmbH & Co. KG
- Smartcanula LLC
- Changzhou KangXin Medical Instruments Co., Ltd.
- NIPRO
- Spectrum Medical
Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.
Conclusion
The cardiac cannula market is expected to witness consistent growth in the coming years, driven by the increasing burden of cardiovascular diseases and the rising demand for advanced surgical interventions. Technological advancements and the growing adoption of minimally invasive techniques are further enhancing market potential. North America continues to lead due to strong healthcare systems and innovation, while emerging regions are gradually expanding their capabilities. The focus on improving patient outcomes and surgical efficiency will remain crucial. Overall, the market is poised for steady expansion, supported by continuous innovation and increasing global healthcare needs.